Respiratory Pathogen Testing Kits Market Insights – Growth & Forecast 2023-2033

Respiratory Pathogen Testing Kits Market Outlook (2023 to 2033)

As per the latest market research conducted by FMI, the global respiratory pathogen testing kits market is expected to record a CAGR of 5.7% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of USD 4,083.1 million. By 2033, the valuation is expected to be worth USD 7,136.8 million.

The most prevalent illnesses that infect people are respiratory tract infections. It has been linked to less serious lower respiratory tract infections (LRTIs), such as pneumonia and bronchitis, as well as self-limiting upper respiratory tract infections (URTIs), like the common cold. Lower respiratory tract infections (LRTIs) have a considerable impact on disease burden and are a leading cause of hospitalization, morbidity, and death in kids and seniors.

The viral respiratory incidents per year in developed countries have been estimated between 5 and 10 in children under the age of six compared to 3 to 6 in those over this age, and acute respiratory infection continues to account for 35% to 45% of hospitalized patients, according to data from the National Institutes of Health. Thus, increasing the respiratory pathogen testing demand to a great extent.

Crucial Growth Factors of the Respiratory Pathogen Testing Kits Market:

• The global market for respiratory pathogen testing kits is expanding as a result of factors like rising chronic illness prevalence, increasing pathogen testing and preventative healthcare awareness, growing manufacturer promotional efforts, and rising public knowledge of respiratory pathogen test equipment. Thus, it is likely to drive the growth of the respiratory pathogen test equipment market in the coming years.
• The availability of enhanced healthcare infrastructure in undeveloped and emerging economies is likely to create profitable demand for respiratory pathogen test devices and drive the growth of the respiratory pathogen test devices market in the future.
• The COVID-19 pandemic had a favorable effect on the market for respiratory pathogen testing kits worldwide. The pandemic increased the need for the respiratory pathogen panel test market to map COVID-19 antibodies for COVID-19 infection and detect molecular tests for the disease.
• Due to a boost in growth for the respiratory pathogen test equipment market, the market for these kits saw a modest increase during the lockdown. As the demand for pathogen test equipment increased to advance diagnostic systems during COVID-19, this has enabled the respiratory pathogen testing kits sector to develop substantially.
• Diagnostic tests have undergone tremendous technological advancement in recent years, which has improved the reliability and accuracy of the identification of respiratory pathogens. Globally, respiratory pathogen testing demand is increasing as a result of this.

Attributes	Value
Respiratory Pathogen Testing Kits Value (2022)	USD 3,852.9 million
Respiratory Pathogen Testing Kits Market Expected Value (2023)	USD 4,083.1 million
Respiratory Pathogen Testing Kits Market Forecast Value (2033)	USD 7,136.8 million
Respiratory Pathogen Testing Kits Market Expected CAGR (2023 to 2033)	5.7%

Key Trends of the Respiratory Pathogen Testing Kits Market

• A massive influx of respiratory illness incidences generates a market opportunity for respiratory pathogen testing kits, which is driven by growth and innovation in the diagnostic and biotech sector.
• Given the increasing preference of consumers for online buying over conventional purchase methods, e-commerce has emerged as a crucial tool for small and sizable enterprises worldwide. This is said to promote the expansion of the market for respiratory pathogen testing kits.

How has the Market Progressed till June 2022?

Particulars	Details
H1, 2021	5.86%
H1, 2022 Projected	6.06%
H1, 2022 Outlook	5.96%
BPS Change - H1, 2022 (O) - H1, 2022 (P)	(-) 10 ↓
BPS Change - H1, 2022 (O) - H1, 2021	(+) 10 ↑

According to Future Market Insights' analysis, the global respiratory pathogen testing kits market expects to increase by 10 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to H1-2022 projected value, the market during the H1-2022 outlook period showed a dip of 10 BPS.

Given the constraints of quick testing, which can't assess widespread coinfection detection, the market for respiratory pathogen testing kits sees a fall in BPS values. Testing kits also have drawbacks, including a lengthy turnaround time, labor-intensive procedures, and low sensitivity.

However, due to the high specificity of RP panel tests for many viruses and bacteria in the respiratory tract, the market is likely to witness an upswing in terms of growth with the introduction of RP tests.

The market is subject to changes as per the regulatory norms and product adoption rates, concerning the macro and industry dynamics. The key developments in the market include the development of PCR-based diagnostic test panels to detect and differentiate common respiratory pathogens simultaneously.

Respiratory Pathogen Testing Kit Demand Analysis (2018 to 2022) Vs Market Outlook (2023 to 2033)

Sales of respiratory pathogen testing kits expanded at a rapid CAGR of 9.8% from 2018 to 2022.

A respiratory pathogen testing kit can be used to detect respiratory infections by analyzing blood, fluids, or samples from the affected area of the body.

Respiratory pathogen testing kits can identify the most common illnesses' genetic material (RNA/DNA). It can recognize a variety of pathogenic bacteria and discover germs that conventional techniques, like blood cultures, can lack. Several test kits can identify specific strains or subgroups of microorganisms.

Uncontrolled ingestion of different gases, such as sulfur dioxide and carbon monoxide, can obstruct the respiratory tract. Many bacterial, fungal, and viral illnesses of the respiratory system can be identified with respiratory pathogen testing kits.

Lateral flow tests, also referred to as immunochromatographic assays, reverse transcription-polymerase chain reaction (RT-PCR) tests, direct fluorescent antibody (DFA) tests, solid-phase assays, agglutination assays, and flow-through assays are among the various types of respiratory pathogen testing.

Chronic Obstructive Pulmonary Disease (COPD) is a lung disease that causes a decline in airflow over time. As per the WHO, low and middle-income nations account for 90% of COPD deaths.

Over 251 million instances of chronic obstructive pulmonary disease were reported globally, according to the Global Burden of Disease survey. In the upcoming years, it is anticipated to increase as the global population ages and people's lifestyles change. The market for respiratory pathogen testing kits is growing as early detection and treatment become more important.

The respiratory pathogen testing kits market is predicted to record a significant CAGR of 5.7% from 2023 to 2033 and is expected to reach a valuation of USD 7,136.8 million by 2033.

Which aspects are Positively Influencing Demand for Respiratory Pathogen Testing Kits?

Increased Research and Development Funding Improve Respiratory Pathogen Testing Systems Sales

Market Growth is Boosted by Increased Funding for Respiratory Diagnostics

• Thermo Fisher acquired Mesa Biotech in February 2021 to strengthen its Life Sciences Solutions business sector. As a result of this acquisition, this segment's revenue increased by over USD 200 million in 2021.

Rising Incidence of Chronic Diseases is Likely to Increase the Usage of Respiratory Pathogen Testing Equipment

• The respiratory pathogen testing devices market is predicted to develop due to the increased use of imaging technologies such as computed tomography (CT) in COPD diagnosis.
• Pulse oximeters are only one example of cutting-edge equipment that is being successfully used in outpatient COPD care. The trend of non-invasive mechanical ventilation for COPD is another factor that is anticipated to fuel market expansion.

Need for Advanced Diagnostic Testing Methods Fuelling Demand for Respiratory Pathogen Testing Kits

• Rapid molecular tests, antigen testing, immunofluorescence assays, vital culture, and real-time polymerase chain reaction (RT-PCR) are the diagnostic techniques accessible to diagnose bacterial and viral infections in the contemporary scenario (reverse transcription-polymerase chain reaction). The ‘PathoDetect COVID-19 Qualitative PCR kit’ was created by Mylab, an Indian company.
• According to the manufacturer, this kit uses the RT-PCR technique to identify infection within 2.5 hours (as compared to 7.5 hours taken previously). Since more diseases can be found in much less time, this factor is expected to increase demand for respiratory pathogen test kits in India and other countries in the Asia Pacific (considering the increasing incidences and population density in this region).
• Staphylococcus Aureus, Moraxella Catarrhalis, Haemophilus Influenzae, And Streptococcus Pneumoniae are among the additional microorganisms that require effective respiratory pathogen testing kits. Apart from the methods stated above, multiplex PCR technology is being used since it provides fast and accurate respiratory pathogen detection.
• Although several respiratory pathogen testing kits sold test for viruses and bacteria, fungi also have a part to play. There may be a rise in demand for these kits globally as a result.
• Rapid molecular tests are a brand-new, highly accurate, and specific type of molecular diagnostic test for influenza. NATs are used for recognizing certain illnesses (Natural Antisense Transcripts). The key advantage of NATs is that they can offer data in a therapeutically relevant period and do not depend on the viability of the target microorganisms.

Strict Laws for the Mining Sector Increase the Usage of Respiratory Pathogen Testing Kits

• Coal miners worldwide are at a high risk of developing non-malignant respiratory conditions like COPD as a result of unintentional intake of silica dust (which contains bacteria).
• In the EU, there are around 53,000 people employed by coal power stations and 185,000 by coal mines. The EU's regulatory body also conducts routine audits of these workers, which boosts demand for respiratory pathogen testing kits.
• There are mining laws and restrictions in places like Australia to ensure the security of coal miners. Coal mining companies are required to have respiratory pathogen testing kits on site as part of environmental regulations.
• Likewise, government safety laws oversee high-risk professions, including coal mining. Some workplaces use respiratory pathogen testing kits as a consequence to report the health status of their employees. It is anticipated that this ongoing need is expected to keep the market for respiratory pathogen testing kits growing.

What aspects are Likely to Limit the Market Expansion for Respiratory Pathogen Testing Kits?

High Product Costs and a Lack of Consumer Awareness are Expected to Restrain the Market's Growth for Respiratory Pathogen Testing Kits.

• The high cost of operating molecular processes (especially by private laboratories) may restrict market expansion in emerging nations, even though molecular diagnostic methods have grown to be a significant component of life science research.
• Together with the development of technological and procedural advances in biotechnology, testing costs have increased.
• The inbound expenditures are borne by the patients. Global players have to therefore stay alert for chances to reduce costs.
• Primary commercial obstacles include a lack of awareness and the occurrence of a sizable underdiagnosed and undertreated population.

Which Regional Markets are Likely to be Profitable for Respiratory Pathogen Testing Kit Providers?

Due to the Rising Prevalence of Respiratory Disorders, North America is likely to have a Significant Market Share

The United States market is projected to be the lucrative market for respiratory pathogen testing kits. The market is anticipated to record a CAGR of 6.6% and is anticipated to continue on this path in the years to come. A sedentary lifestyle, along with COVID-19 and other existing viral, bacterial, and fungal diseases, is driving the market in this region.

Crucial Revenue Stimulator for Asia Pacific

In response to the increased cases of COVID-19, the respiratory pathogen testing kit market in the Asia Pacific is gaining momentum. Air pollution is another market-stimulating factor. More than 20 of the most polluting nations in the world are located in the Asia Pacific, according to IQAir. Sales of respiratory pathogen testing kits are rising as a result of the congestion of the respiratory tract brought on by uncontrolled ingestion of carbon monoxide and sulfur dioxide.

How is China's Market for Respiratory Pathogen Testing Kits Expanding?

The top genomics company in the world, BGI Group, has partnered with China's military on projects ranging from mass testing for respiratory viruses to brain science, according to a Reuters review of research, patent filings, and other publications.

According to an analysis of more than 40 publicly available documents and research articles in Chinese and English, BGI has connections to the People's Liberation Army (PLA), including research with China's top military supercomputing professionals. China was the location where the COVID-19 pandemic started, and it swiftly spread throughout the world. Since that time, the diagnostic industry has expanded rapidly.

Growth Outlook of Country-wise Insights

Countries	United States
CAGR (2018 to 2022)	10.6%
CAGR (2023 to 2033)	6.6%
Valuation (2033)	USD 2,438.4 million

Countries	United Kingdom
CAGR (2018 to 2022)	7.6%
CAGR (2023 to 2033)	6.0%
Valuation (2033)	USD 379.2 million

Countries	China
CAGR (2018 to 2022)	10.1%
CAGR (2023 to 2033)	6.3%
Valuation (2033)	USD 585.7 million

Countries	Germany
CAGR (2018 to 2022)	10.3%
CAGR (2023 to 2033)	6.0%
Valuation (2033)	USD 552.6 million

Category-wise Analysis

Which Technology Enables the Market for Respiratory Pathogen Testing Kits to Grow the Most?

A type of viral diagnostic test known as a Nucleic Acid Amplification Test, or NAAT, is used to identify SARS-CoV-2, the virus that causes COVID-19. Genetic material detectors are NAATs (nucleic acids). The RNA (ribonucleic acid) sequences that make up the virus' genetic information are precisely identified by SARS-CoV-2 NAATs.

NAATs are utilized for SARS-CoV-2 test samples from the upper or lower respiratory tracts. The type of specimen used for SARS-CoV-2 testing depends on both the test being run and the manufacturer's instructions.

The advancement of nucleic acid amplification testing technology is being fueled by the rising incidence of contagious diseases, the growing demand for better diagnostic tools, and increased funding for the creation of novel biotechnological diagnostic techniques. Now, nucleic acid amplification testing is anticipated to hold a 44.6% market share overall.

Competitive Background

The presence of several manufacturers and key market players operating at the worldwide level defines the respiratory pathogen testing kits market. Leading respiratory pathogen testing equipment manufacturers are concentrating their efforts on developing unique testing kits that are expected to aid in obtaining results quickly. They are investing heavily to get a competitive advantage over one another.

Significant Key Players in the Market:

• Thermo Fisher Scientific
• Abbott Laboratories
• Danaher Corporation
• Becton, Dickinson and Company
• Hoffmann-La Roche Ltd.
• bioMérieux Inc.
• Altona Diagnostics
• MyLab

Recent Development:

• In November 2021, Philips added more powerful imaging tools and features to its ultrasound solution for Radiology, improving workflow effectiveness and diagnostic certainty.

Respiratory Pathogen Testing Kits Industry Report Scope

Attribute	Details
Forecast Period	2023 to 2033
Historical Data Available for	2018 to 2022
Market Analysis	USD billion for Value, Units for Volume
Key Regions Covered	North America; Latin America; Europe; East Asia; South Asia & Pacific; The Middle East & Africa (MEA)
Key Countries Covered	United States, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, China, Japan, South Korea, India, Indonesia, Malaysia, Singapore, Australia, New Zealand, Türkiye, South Africa, GCC Countries
Key Market Segments Covered	Product, Infection/Symptom, Technology, End User, Region
Key Companies Profiled	Thermo Fisher Scientific; Abbott Laboratories; Danaher Corporation; Becton, Dickinson, and Company; Hoffmann-La Roche Ltd.; bioMérieux Inc.; Altona Diagnostics; MyLab
Pricing	Available upon Request

Table of Content

• 1. Executive Summary | Respiratory Pathogen Testing Kits Market
• 2. Market Overview
• 3. Market Background
• 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
• 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
  • 5.1. RT PCR Kits
  • 5.2. DFA Kits
  • 5.3. ELISA Kits
• 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Infection
  • 6.1. Enterovirus Infection
  • 6.2. Human Coronavirus Infection
  • 6.3. Influenza Virus Infection
  • 6.4. Respiratory Syncytial Virus Infection
  • 6.5. Rhinovirus Infection
• 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
  • 7.1. Hospitals
  • 7.2. Diagnostic Centres
  • 7.3. Speciality Clinics
• 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
  • 8.1. North America
  • 8.2. Latin America
  • 8.3. Europe
  • 8.4. South Asia
  • 8.5. East Asia
  • 8.6. Oceania
  • 8.7. MEA
• 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 16. Key Countries Market Analysis
• 17. Market Structure Analysis
• 18. Competition Analysis
  • 18.1. Thermo Fisher Scientific
  • 18.2. Abbott Laboratories
  • 18.3. Danaher Corporation
  • 18.4. Becton, Dickinson and Company
  • 18.5. Hoffmann-La Roche Ltd.
  • 18.6. bioMérieux Inc.
  • 18.7. Altona Diagnostics
  • 18.8. Mylab Discovery Solutions Pvt Ltd.
  • 18.9. Siemens Healthineers AG
  • 18.10. Sysmex Corporation
• 19. Assumptions & Acronyms Used
• 20. Research Methodology